IP Library Granted Patent US 10,512,694
Granted Patent B2
US 10,512,694 · App. 15/655,669 · Granted Dec 24, 2019

Compositions for oral drug administration

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,512,694
App. No.
15/655,669
Granted
Dec 24, 2019
Kind
B2
Abstract

The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms. In various aspects, the invention provides compositions and methods for oral delivery in the form of a tablet.

Claims (4)

1. A method of increasing the bioavailability of an active ingredient in a subject comprising orally administering an absorption increasing amount of an alkylglycoside with the active ingredient, in solid dosage form, wherein the active ingredient is phenylephrine and the alkylsaccharide is dodecyl-beta-D-maltoside, thereby increasing the bioavailability of the active ingredient in the subject.

2. The method of claim 1 , wherein the solid dosage form is a tablet.

3. The method of claim 1 , wherein C max is 2, 3, 4, 5, 6, 7, 8 or 9-fold greater as compared to delivery without alkylglycoside.

4. The method of claim 1 , wherein the alkylglycoside concentration is between about 0.05% and 10% (w/v).

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →
SECURITY INTEREST Recorded Aug 6, 2021
From: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057111/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2018
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 045353/0220 →